Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30 count bottle, OTC Manufactured by Sun Pharma, Gujarat, India, NDC 47335-343-83
Published May 7, 2014 · Recall initiated: April 9, 2014
Summary
FDA records drug Class III recall D-1296-2014, published May 7, 2014 and initiated April 9, 2014. Recalling firm: Caraco Pharmaceutical Laboratories, Ltd.; Status: Terminated; Reported quantity: 128,363 bottles; Lot: JKM2067A Exp. 07/14, JKM2068A Exp.10/14, JKM2069A Exp. 01/15, JKM6399A Exp. 04/15. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: out of specification results for impurities/degradation testing for N-Oxide
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Caraco Pharmaceutical Laboratories, Ltd.
- Distributor
- Nationwide
- Lot
- JKM2067A Exp. 07/14, JKM2068A Exp.10/14, JKM2069A Exp. 01/15, JKM6399A Exp. 04/15
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACephalexin Capsules, USP, 500 mg, packaged in a) 100-count bottles (NDC 62756-294-88) and b) 500-count bottlesAugust 13, 2014
- FDACephalexin Capsules, USP, 250 mg, packaged in a) 100-count bottles (NDC 62756-293-88) and b) 500-count bottlesAugust 13, 2014
- FDAVenlafaxine Hydrochloride Extended-Release Tablets, 150 mg, Rx only, Packaged in 30 Count and 90 CountJuly 9, 2014
- FDAGemcitabine For Injection USP, 1 g, (lyophilized), For Intravenous Use Only, Sterile Single Use Vial, Rx only,July 2, 2014
- FDALupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilledMay 7, 2014
- FDAChildren's Cetirizine Hydrochloride Chewable Tablets, 10 mg, 30 count bottle, OTC, Manufactured by Sun Pharma,May 7, 2014
Questions about this recall
Was Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30 count bottle, OTC Manufactured by Sun Pharma, Gujarat, India, NDC 47335-343-83 recalled?
Yes. FDA published recall D-1296-2014 on May 7, 2014. Reported hazard: Failed Impurities/Degradation Specifications: out of specification results for impurities/degradation testing for N-Oxide
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit